{"version":"1.0","provider_name":"Site da Brakke Consulting","provider_url":"https:\/\/brakkeconsulting.com\/pt","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"EGNA5P8FQZ\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/23503\/\">Not\u00edcias e notas de sa\u00fade animal de 16 de novembro de 2001<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/pt\/23503\/embed\/#?secret=EGNA5P8FQZ\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for November 16, 2001&#8221; &#8212; Brakke Consulting Website\" data-secret=\"EGNA5P8FQZ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for November 16, 2001 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company Earnings Releases &gt;&nbsp; Bayer reported that for the third quarter 2001, Animal Health sales rose by 1%, while in the first three quarters as a whole business was down 4% to 0.7 billion euros ($635 million). The divestiture of the U.S. livestock vaccines business had a negative effect of 1 and 4 percentage points, respectively. The parasiticide Advantage again showed encouraging growth in the United States and Japan. (company website) &gt;&nbsp; Alpharma Inc. announced that the financial results for the third quarter and nine months ended September 30, 2001 previously announced in a press release on November 6, 2001 differed, for the reasons disclosed below, from those filed today on Form 10-Q with the Securities and Exchange Commission.&nbsp; Results for the third quarter and nine months in 2001 are lower than those previously announced by the following: revenue, $17.5 million; gross profit, $10.3 million and net income, $7.1 million. Subsequent to the announcement of results on November 6, oral representations were alleged by certain customers of the Animal Pharmaceutical business that resulted in a difference in understanding of key terms and conditions related to third quarter sales to these customers. As a result, the Company has modified the revenue recognition forView Full Post;"}